MedTrace Logo

A Self-management Based Survivorship Intervention for Chinese Cancer Survivors

NCT05534386 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 486

Last updated 2025-05-13

No results posted yet for this study

Summary

This study, using a sequential multiple assessment randomized controlled trial (SMART) approach, will evaluate a cancer survivorship care intervention on physical symptom distress, weight management, self-efficacy in managing cancer and health-related quality of life among Chinese patients recently completed curative cancer treatment.

Conditions

Interventions

BEHAVIORAL

Cancer survivorship care intervention

A one-off face-to-face assessment and personal advice by members of a multidisciplinary team

BEHAVIORAL

Step-up targeted personalized intervention

To provide a more personalized intervention to the participants, but focusing more on symptom management and weight control.

BEHAVIORAL

First stage control intervention

A set of skill-based pamphlets will be given.

BEHAVIORAL

Second stage control intervention

Those in the survivorship clinic arm will be asked to follow the advice given by the multidisciplinary team in the initial visit and for those in the control arm will be asked to follow the advices printed in the skill-based self-management pamphlet

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Wendy Wing Tak Lam, PhD · School of Public Health, The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-12
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05534386 on ClinicalTrials.gov